Margin Recovery Under Scrutiny as Valuation Premium Persists

JTEKT India was upgraded to Buy on August 5, 2026, with a ₹192 target (36% upside from current levels). The bull case rests on three pillars: (1) gross margin recovery as input costs soften, (2) the CVJ (Constant Velocity Joint) driveline ramping at 45% CAGR from a small base (4% of revenue), and (3) EV portfolio and export expansion driving mix improvement. However, at 47.7x trailing P/E and a PEG of 24.9, the stock is priced for near-flawless execution. Street consensus for FY27E is 5–6% revenue growth but a 13% decline in EPS—a critical divergence that puts the valuation thesis on trial.

A strong quarter would show gross margin recovery to 28%+, CVJ driveline volume momentum accelerating, and management confirming 8–10% FY27 revenue guidance. A weak quarter would be flat or declining gross margins, softer auto volumes, or CVJ ramp delays.

JTEKT India outperformed the auto market in FY26 (11% revenue growth vs. 9% market growth), and gross margin erosion appears input-cost driven rather than competitive. The company's conservative leverage (debt-to-equity 0.09x) and new capacity initiatives (₹6.5 billion Gujarat facility, export scaling from ~3% to 8% of sales) support long-term growth. However, the near-term EPS headwind creates a timing risk: if earnings decline while multiples stay at 47.7x, near-term returns are capped. Management guidance on margin recovery, CVJ scale, and FY27 full-year outlook will be critical.

The dividend at ₹0.75 (75% payout) signals confidence in cash generation—at ₹141 stock price, this yields ~5.3%, attractive for income investors. However, tax headwinds are material: a ₹622.39 Cr MEIS duty recovery demand is roughly 20% of trailing quarterly revenue run-rate and remains in Show Cause stage. Income tax demands (₹137.36 Mn for FY23) and state entry tax notices are worth monitoring for escalation, though typical regulatory friction at this scale.